Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Hayes

Showing results (101-110 of 130) with videos related to

Pageof 13
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 6, 2025
Liver Failure, Hepatic Encephalopathy, and Infection Contribute to Mortality Risk in a Global Cirrhosis CohortJasmohan S Bajaj, Scott Silvey, Aidan Mullan, et al.
Hepatology (Baltimore, Md.)|November 3, 2011
Excess liver-related morbidity of chronic hepatitis C patients, who achieve a sustained viral response, and are discharged from careHamish A Innes, Sharon J Hutchinson, Samuel Allen, et al.
European Journal of Gastroenterology & Hepatology|March 22, 2012
Ranking predictors of a sustained viral response for patients with chronic hepatitis C treated with pegylated interferon and ribavirin in ScotlandHamish A Innes, Sharon J Hutchinson, Samuel Allen, et al.
Frontiers in Immunology|December 19, 2022
Assessment of a diverse panel of transmitted/founder HIV-1 infectious molecular clones in a luciferase based CD8 T-cell mediated viral inhibition assayNatalia Fernandez, Peter Hayes, Julia Makinde, et al.
Journal of Hepatology|August 23, 2016
Mortality in hepatitis C patients who achieve a sustained viral response compared to the general populationHamish Innes, Scott McDonald, Peter Hayes, et al.
Frontiers in Immunology|March 29, 2021
A Novel Sample Selection Approach to Aid the Identification of Factors That Correlate With the Control of HIV-1 InfectionJulia Makinde, Eunice W Nduati, Anna Freni-Sterrantino, et al.
BMJ Open Gastroenterology|March 22, 2024
Study protocol for a Randomised controlled trial of EArly transjugular intrahepatiC porTosystemic stent-shunt in Acute Variceal Bleeding (REACT-AVB trial)Dhiraj Tripathi, David Patch, Homoyon Mehrzad, et al.
Clinical Chemistry|March 9, 2010
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in liver, bladder, cervical, and gastric cancersCatharine M Sturgeon, Michael J Duffy, Barry R Hofmann, et al.
The Journal of Infectious Diseases|February 6, 2010
Viral inhibition assay: a CD8 T cell neutralization assay for use in clinical trials of HIV-1 vaccine candidatesAggeliki Spentzou, Philip Bergin, Dilbinder Gill, et al.
Clinical and Vaccine Immunology : CVI|January 25, 2013
Safety and immunogenicity of DNA prime and modified vaccinia ankara virus-HIV subtype C vaccine boost in healthy adultsPeter Hayes, Jill Gilmour, Andrea von Lieven, et al.
Pageof 13

Showing results (101-110 of 130) with videos related to

Sort By:
Pageof 13
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 6, 2025
Liver Failure, Hepatic Encephalopathy, and Infection Contribute to Mortality Risk in a Global Cirrhosis CohortJasmohan S Bajaj, Scott Silvey, Aidan Mullan, et al.
Hepatology (Baltimore, Md.)|November 3, 2011
Excess liver-related morbidity of chronic hepatitis C patients, who achieve a sustained viral response, and are discharged from careHamish A Innes, Sharon J Hutchinson, Samuel Allen, et al.
European Journal of Gastroenterology & Hepatology|March 22, 2012
Ranking predictors of a sustained viral response for patients with chronic hepatitis C treated with pegylated interferon and ribavirin in ScotlandHamish A Innes, Sharon J Hutchinson, Samuel Allen, et al.
Frontiers in Immunology|December 19, 2022
Assessment of a diverse panel of transmitted/founder HIV-1 infectious molecular clones in a luciferase based CD8 T-cell mediated viral inhibition assayNatalia Fernandez, Peter Hayes, Julia Makinde, et al.
Journal of Hepatology|August 23, 2016
Mortality in hepatitis C patients who achieve a sustained viral response compared to the general populationHamish Innes, Scott McDonald, Peter Hayes, et al.
Frontiers in Immunology|March 29, 2021
A Novel Sample Selection Approach to Aid the Identification of Factors That Correlate With the Control of HIV-1 InfectionJulia Makinde, Eunice W Nduati, Anna Freni-Sterrantino, et al.
BMJ Open Gastroenterology|March 22, 2024
Study protocol for a Randomised controlled trial of EArly transjugular intrahepatiC porTosystemic stent-shunt in Acute Variceal Bleeding (REACT-AVB trial)Dhiraj Tripathi, David Patch, Homoyon Mehrzad, et al.
Clinical Chemistry|March 9, 2010
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in liver, bladder, cervical, and gastric cancersCatharine M Sturgeon, Michael J Duffy, Barry R Hofmann, et al.
The Journal of Infectious Diseases|February 6, 2010
Viral inhibition assay: a CD8 T cell neutralization assay for use in clinical trials of HIV-1 vaccine candidatesAggeliki Spentzou, Philip Bergin, Dilbinder Gill, et al.
Clinical and Vaccine Immunology : CVI|January 25, 2013
Safety and immunogenicity of DNA prime and modified vaccinia ankara virus-HIV subtype C vaccine boost in healthy adultsPeter Hayes, Jill Gilmour, Andrea von Lieven, et al.
Pageof 13